Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Measuring the Costs and Benefits of Pharmaceutical Expenditures

This paper presents a methodological approach for analyzing growth in pharmaceutical expenditures, enabling researchers to disaggregate growth into price and volume components. Research using this methodology (see Explaining Drug Spending Trends: Does Perception Match Reality?) has found increased volume, not price, is the primary driver of pharmaceutical spending growth.

Newsletter Volume

E.V.I.dently October 2013

Message from NPCWhen Health Insurance Exchange “Dust” Settles, Usable CER Will Be CriticalBy Dan LeonardOn October 1, the debut of the federal...
Blog Post

Catch These Upcoming Events and Publications

September was a particularly busy month, featuring a variety of health care conferences, meetings, publications, and ongoing debates about the...
YouTube Videos

Rapid-Learning Health Care Systems, Explained

Dr. Lucy Savitz, director of research and education, Institute for Healthcare Delivery Research, Intermountain Healthcare, explains rapid learning...
Newsletter Volume

E.V.I.dently July 2013

Message From NPCTransforming “Knowing” into “Doing”By Robert W. Dubois, MD, PhDThe pace of medical discovery and innovation has accelerated in recent...
Press Release

Study Quantifies Impact of Pharmaceuticals on Enhanced Productivity

(WASHINGTON, DC, August 1, 2012)–The costs to employers of chronic health conditions on employee productivity are well documented, but few studies...
Press Release

Pharmaceuticals Play Key Role in Achieving ACO Quality, Cost Goals

WASHINGTON, DC, July 18, 2012–As health care providers set up accountable care organizations (ACOs) and other value-based care programs,...
Press Release

New Survey Shows Employers Eyeing CER, PCORI for Health Information

Washington, DC, June 22, 2011--Employers are aware of comparative effectiveness research (CER) and its potential to answer critical questions about...
Press Release

Study Sheds New Light on the Impact of Medication Adherence, Multiple Chronic Diseases and Health Risks in the Workplace

(Chicago -- June 16, 2011) A new study suggests that while medication adherence is a critical element in reducing the impact of illness, employers...
Commentary and Testimony Page

Living Up to Its Name? The Role of Patient-Centered Research

Anyone who has ever received bad news from his or her health care provider or held a loved one’s hand when a diagnosis was delivered can understand...
Commentary and Testimony Page

High Stakes for Setting Research Standards

What is the cost of poorly designed research? In the comparative effectiveness arena, faulty studies could mean that consumers may make important...
Commentary and Testimony Page

Asymmetry in the Ability to Communicate CER Findings: Ethics and Issues for Informed Decision Making

The number of voices in the comparative effectiveness research (CER) conversation is continuing to grow, but not all stakeholders have the same...
Commentary and Testimony Page

CER Done Right: Why It Matters

The health care reform law is aimed at reshaping the health care landscape through the creation of many new regulations and regulatory...
YouTube Videos

Rapid-Learning Health Care Systems, Explained

Dr. Lucy Savitz, director of research and education, Institute for Healthcare Delivery Research, Intermountain Healthcare, explains rapid learning...
YouTube Videos

IBI's Tom Parry on Employers and Health Investments

Integrated Benefits Institute President Tom Parry, PhD, sat down with NPC to discuss how employers today are defining the value of their health...
Blog Post

Catch These Upcoming Events and Publications

September was a particularly busy month, featuring a variety of health care conferences, meetings, publications, and ongoing debates about the...
Blog Post

Medication Adherence: Americans Earn Poor Marks in Recent Report

We know that optimizing the use of medicine plays an important role in lowering costs and improving health outcomes. So how are our nation’s patients...
Blog Post

The Role of Pharmaceuticals in Health Insurance Exchanges

As part of the implementation of the Affordable Care Act, a series of state health insurance exchanges are being established across the United States...
Blog Post

CER Communications: Helping Patients Make Informed Decisions

Any guidelines for communicating comparative effectiveness research (CER) must focus on positioning patients to make informed decisions about their...

Research

Imputing Productivity Gains From Clinical Trials

Researchers developed a new method to capture the impact that medicines may have on reducing the...

Role of Pharmaceuticals in Value-Based Healthcare: A Framework for Success

This research sets out a conceptual framework for considering the role of pharmaceuticals in...

Blue Pill or Red Pill: The Limits of Comparative Effectiveness Research

By choosing "winners and losers," CER drug trials may leave patients who best respond to the "...
  •  
  • 1 of 28
  • >

Commentary & Testimony